New York University Medical Center (Site 200) — New York, New York

New York University Medical Center (Site 200) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

New York University Medical Center (Site 200) has participated in 2 clinical trials.

Therapeutic areas: NF1, Low-grade Glioma, Neurofibromatosis 2.

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Medical Center (Site 200)?

New York University Medical Center (Site 200) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Medical Center (Site 200) conducted?

New York University Medical Center (Site 200) has 2 clinical trials on record. Their work covers NF1, Low-grade Glioma, Neurofibromatosis 2.

Is New York University Medical Center (Site 200) accredited by Crixeo Health?

New York University Medical Center (Site 200) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University Medical Center (Site 200)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.